These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry, BioSpace.com Breaking… Source: BioSpace You Might Also Like Peregrine Slashes Workforce by 20% in Cost Cutting Plan August 10, 2017 Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ January 21, 2018 GlaxoSmithKline CEO Continues Restructuring With Job Cuts in Africa January 17, 2018
